News
2011;68(15):1419-1425. The short duration of activity of naloxone when the drug is administered as an i.v. bolus may limit its effectiveness for the management of OIP. Intravenous access may not ...
No description, website, or topics provided.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results